LaserSight Excimer Laser Sales On Hold Pending Visx License Negotiations

LaserSight says it will delay marketing of the LaserScan LSX ophthalmic excimer laser system in the U.S. while it negotiates a license agreement with competitor Visx.

More from Archive

More from Medtech Insight